CREABILIS Therapeutics Srl - Company Review
SummaryCREABILIS Therapeutics Srl - Company Review
Summary
CREABILIS Therapeutics Srl (Creabilis), a subsidiary of Creabilis Ltd is a pharmaceutical company that develops dermatology products. The company's pipeline products include CT200 and CT335, and CT327 which is used in the treatment of dermatology diseases such as atopic dermatitis, psoriasis and overgrowth of keratinocytes. It also offers an HMGB1 antagonist used to the treat a variety of inflammatory conditions. Creabilis provides a potent narrow spectrum kinase inhibitor for the topical treatment of chronic pruritus. The company uses low systemic exposure technology to generate preclinical development molecules to treat inflammatory diseases such as atopic dermatitis, psoriasis and inflammatory bowel disease. Creabilis is headquartered in Turin, Italy.
This comprehensive company report of CREABILIS Therapeutics Srl provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.